Cardiology
Conference Coverage
High CV risk factor burden in young adults a ‘smoldering’ crisis
Cardiovascular risk factors are “unacceptably” high and are increasing among young adults, prompting calls for aggressive preventive measures.
Conference Coverage
COORDINATEd effort boosts optimal therapy in patients with T2D and ASCVD
News
Med center and top cardio surgeon must pay $8.5 million for fraud, concurrent surgeries
A lawsuit alleges that James L. Luketich, MD, regularly performed up to three complex surgical procedures simultaneously.
News
Biomarkers linked to elevated T2D MACE risk in DECLARE-TIMI 58
A secondary DECLARE-TIMI 58 trial analysis linked two biomarkers to higher cardiovascular risks in diabetes and found a strong benefit of...
Conference Coverage
NUDGE-FLU: Electronic ‘nudges’ boost flu shot uptake in seniors
Two strategies based on electronically delivered letters or “nudges” were found to increase flu shot uptake, compared with usual care, a new study...
Conference Coverage
Atorvastatin cut anthracycline cardiac dysfunction in lymphoma
Conference Coverage
Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL cholesterol–lowering therapies, experts say...
Conference Coverage
500 more steps a day tied to 14% lower CVD risk in older adults
New study supports the value of modest but consistent activity to improve heart health.
News
FDA declines approval for omecamtiv mecarbil in HFrEF
The Food and Drug Administration’s decision followed the consensus of its advisory committee.
Conference Coverage
Old drug verapamil may have new use in type 1 diabetes
In randomized trial, the old cardiac agent slowed the destruction of insulin-producing beta cells in youth with new-onset type 1 diabetes.